Condition: Retinal Disease · Age-Related Macular Degeneration · Retinitis Pigmentosa · Sponsor: MD Stem Cells
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
This description comes directly from the study's public registry record.
Steven Levy, MD · 203-423-9494 · stevenlevy@mdstemcells.com
Steven Levy, MD · 203-423-9494
Always discuss trial participation with your own doctor first.
| MD Stem Cells | Westport, Connecticut, United States | Recruiting |
| MD Stem Cells | Coral Springs, Florida, United States | Recruiting |
| MD Stem Cells Kobinia Med | Vienna, Austria, Austria | Recruiting |
| The Saudi-German Hospital | Dubai, United Arab Emirates, United Arab Emirates | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03011541